Bahiru Bergene

Knowledge, attitudes, and practices toward dolutegravir-based antiretroviral therapy among people living with HIV receiving ART at Bule Hora University steaching hospital, Ethiopia: a cross-sectional study

Abstract Background Dolutegravir (DTG)-based antiretroviral therapy (ART) is the World Health Organization (WHO)-recommended first-line regimen because of its high efficacy, favourable safety profile, and high genetic barrier to resistance. Although Ethiopia has adopted DTG-based...